Category: TRXC

1st Quarter 2019 – Update

1st Quarter 2019 – Update

PRPO – Precipio, Inc. As expected, the reverse split has been completed. So, how far down will we decline? While the company press releases have been positive over the last few months, the underlying fundamentals and financial environment that led to the slow decline, I believe, remains in place. Anticipated in the upcoming few weeks,…

Read More Read More

3rd Quarter 2018 – Portfolio Update

3rd Quarter 2018 – Portfolio Update

The year has been pretty positive so far with the markets and economy showing impressive gains. Hope you as well are being rewarded with gains. Below are my updates on my picks for the third quarter.   TRXC – TransEnterix is still showing signs of decent growth. The new addition of a commercial officer should…

Read More Read More

3rd Quarter 2017 – Growth Portfolio Update

3rd Quarter 2017 – Growth Portfolio Update

AXN – As mentioned in the recent Aoxing Pharmaceutical blog, I ended my position in this stock as the company announced a delisting of their common stock. The remaining proceeds have been reinvested into 22nd Century Group and TransEnterix Inc. OBCI – Continuing to hold steady in this growth stock as it tracks towards $6.…

Read More Read More